Task group to fast-track Covid drugs availability

By Red Mendoza

Feb 23, 2023 12:45 am

(UPDATE) THE Food and Drug Administration (FDA) has launched 'Task Force Fleming' to streamline the approval and evaluation process of Covid-19 drugs without compromising their quality and safety.

FDA Director-General Samuel Zacate said that there will no longer be the issuance of emergency use authorization (EUA), instead, Covid-19 drugs issued with certificates of product registration (CPR) will be made quickly available to the public under the supervision of Task Force Fleming.

FDA Director-General Samuel Zacate. Photo from Food and Drug Administration

Already have an active account? Log in here to continue reading.
Or
Subscribe to the Premium Subscription plan to access this subscriber-exclusive article.

Related Articles

DOH warns of more respiratory diseases

IRR for seafarers Magna Carta signed

6M devotees expected at Traslacion

Massive EDSA rehab set this year

28 DSWD programs exempted from ban

Angara says more classrooms to be built

Malabon ends trash collector's contract